Sendad, Amerah .

HRN: 07-53-21  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/06/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/06/2025
09/12/2025
IV INFUSION
500mg
Q8
Post D&C
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines